Biotechnology News

October 10, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced that clinical and pre-clinical...

October 10, 2014

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has concluded its review...

October 10, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Announces YTD Results for Fiscal Year End 2014

October 10, 2014

FRANKFURT, Germany--(BUSINESS WIRE)--Janssen R&D Ireland (Janssen) today announced the presentation of additional data for the NS3/4A protease inhibitor OLYSIO® (simeprevir) at the Viral Hepatitis Congress (VHC) in Frankfurt, Germany. The...

October 10, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement made by Diagenic ASA (“Diagenic” or the “Company”)(OSE:DIAG) yesterday, 9 October 2014, regarding the Minutes from the Extraordinary General...

October 10, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement made by Diagenic ASA (“Diagenic” or the “Company”)(OSE:DIAG) yesterday, 9 October 2014, regarding the Minutes from the Extraordinary General...

October 10, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Aymeric Le Chatelier as Executive Vice President, Chief Financial Officer effective as of 3 November 2014. He will report directly to...

October 9, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today the pricing of its offering of $75,000,000 aggregate principal amount of 2.00% Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private...

October 9, 2014

LONDON--(BUSINESS WIRE)--According to a new peer-reviewed study published in the International Journal of Angiology, a natural extract made from the bark of pine trees may significantly improve the appearance, swelling and discomfort of pregnancy...

October 9, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences announced that Medicare has issued its final national coverage decision for the company's Cologuard test.

October 9, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, continues to innovate in the treatment of complex deformity with the launch of the SILC™ Fixation System. SILC™ is a low profile...

October 9, 2014

MONONA, Wis.--(BUSINESS WIRE)--SHINE announced today that it executed a term sheet providing for up to $125M with Deerfield. SHINE will use the funds to build a plant to produce more than a quarter of world supply of molybdenum-99.

October 9, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced the publication of the results from the SOLO II Phase 3 clinical trial of ORBACTIV (oritavancin) for injection in the journal Clinical Infectious Diseases....

October 9, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host a quarterly conference call to discuss its third quarter 2014 financial results on Thursday, October 16, 2014, at 7:30 a.m. Central Time. Beginning in the third...

October 9, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien today announced U.S. Food and Drug Administration 510(k) clearance for the Nellcor™ Portable SpO2 Patient Monitoring System (PM10N).

October 9, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fourth quarter and fiscal year ended July 31, 2014, with continued solid year-end gains posted by both Life Sciences and Clinical Labs. Fourth quarter revenues...

October 9, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today it has entered into an agreement providing for up to $125 million of debt and equity financing for SHINE Medical Technologies, Inc. The financing is milestone based with the...

October 9, 2014

WEST CHESTER, Ohio--(BUSINESS WIRE)--The AtriCure ABLATE Post Approval Study enrollment is complete, This is the largest study of its kind to evaluate surgical ablation for treatment of Afib using the AtriCure Synergy Ablation System.

October 9, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori US Trade Mission

October 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S. Food and Drug Administration (FDA) has approved VELCADE® (...

October 9, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News : Transgene SA (Paris:TNG) (NYSE-Euronext: TNG) announced today the further strengthening of its management team following the recent arrival of Eric Quémeneur as Executive Vice President, Vice...

October 9, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation, the leading provider of technologies used to collect patient-driven eData for clinical research, has completed self-certification of compliance with the Safe Harbor Framework.

October 9, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, recounted today the significant number of scientific posters...

October 9, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announced that its investee, Neovasc, has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the U.S. arm of its...

October 9, 2014

NEW YORK--(BUSINESS WIRE)--ClinTec International and Edinburgh Napier University are delighted to announce that the Asia Training Consortium has endorsed the Masters in International Clinical Research and Technology for clinical research...

October 9, 2014

NEW YORK--(BUSINESS WIRE)--Accenture has announced the launch of Accenture Life Sciences Cloud for R&D.

October 9, 2014

ATLANTA--(BUSINESS WIRE)--Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis

October 9, 2014

JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announces the engagement of...

October 9, 2014

ROCHESTER, Minn.--(BUSINESS WIRE)--International Medica Foundation licensed to BravoVax Co. the worldwide rights (excl. US, EU and Japan) to a rotavirus vaccine that can protect infants earlier in life from life-threatening diarrhea.

October 9, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it disclosed on October 3, 2014, through which BioTime received $29,425,961 and certain subsidiaries received approximately $1...

October 9, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Unites its World-Class Arrow, Hudson RCI, LMA and Rusch Brands at Anesthesiology 2014

October 9, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--ZGSI establishes two operating subsidiaries as the Company enters revenue generation and BAM-FX commercialization.

October 9, 2014

MONROVIA, Calif.--(BUSINESS WIRE)--Immunotech Laboratories, Inc. (OTCMARKETS: IMMB) Immunotech Laboratories, Inc.(the “Company”) and Immunotech Laboratories, BG (IMMB-BG”) the Company announced today that they have entered into negotiations with...

October 9, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research issues an open letter to shareholders addressing the market reaction to data contained in the ARC-520 AASLD abstract

October 9, 2014

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--New data from an ongoing study indicates the BluePrint genomic test provides information about the molecular subtype of breast cancer that adds value beyond IHC-FISH pathology testing.

October 9, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: The extraordinary general meeting of DiaGenic ASA (OSE:DIAG) was held on 9 October 2014. All proposals set out in the notice to the general meeting were approved. Please find minutes from the ...

October 9, 2014

PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical will exhibit at the 2014 Biomedical Engineering Society Annual Meeting, October 22–25.

October 9, 2014

CAMBRIDGE, Mass. & DUBLIN--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Actavis plc (NYSE: ACT) announced today that the following linaclotide-related data will be presented during the American College of...

October 9, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a leader in the development of therapies for immuno-oncology, announced today that Thomas W. Dubensky, Jr., Ph.D., chief scientific officer at the company, was a featured speaker at the...

October 9, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced the appointment of Gary Lyons to the Board of Directors as a third independent director. This addition brings the Company into compliance with the independent director and...

October 9, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart Inc., a privately held, clinical-stage company developing recombinant vaccines that are administered by tablet rather than by injection, today announced that Wouter Latour, MD, chief executive...

October 9, 2014

WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics presented data at today's NCI Immunotherapy meeting. Intensity’s lead product eliminated large tumors and caused a protective immune response in mice with colon cancer.

October 9, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions will hold its 3rd quarter 2014 financial results conference call at 5:00PM Eastern on Thursday, November 6, 2014.

October 9, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has been named by FierceMedicalDevices to its...

October 9, 2014

SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Scientific, Inc., DBA Great Basin Corporation, a commercial-stage molecular diagnostics company, today announced the pricing of its firm commitment, underwritten initial public offering of 1,150,000...

October 9, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that NovaBay’s i-Lid...

October 9, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--The Board of Directors of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Leonard Bell, M.D. has been appointed Chairman of the Board of Directors.

October 9, 2014

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (“the Company”) announced today financial results for its first quarter ended August 31, 2014. First Quarter Financial Results Consolidated net sales increased 6.0% (5.6% constant currency) worldwide to...